Find and Pitch Jounalists, Get Your Story Covered

Tags: nasopharyngeal carcinoma adverse reactions chemotherapy hypothyroidism gemcitabine

	Profile	Recent Articles on Subject
1	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 5 days ago Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC With Adagrasib - 6 months ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	No PFS Benefit With Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma - 6 days ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 7 months ago Two Pembrolizumab Trials in Head and Neck Cancer Yield Divergent Results - 7 months ago Immunotherapy May Hold Promise for Skin Cancers After Kidney Transplant - 7 months ago CAR-T Investigation: FDA Leaders Detail Decision on Cancer Risk Warning - 8 months ago FDA Approves Belzutifan for Advanced Renal Cell Carcinoma - 9 months ago Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug - 10 months ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - 10 months ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - 10 months ago Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations - 10 months ago FDA OKs New Option for Advanced ROS1-Positive Lung Cancer - 10 months ago RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer - 11 months ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - 11 months ago Can ctDNA Guide Radiation Use in Oligometastatic NSCLC? - 12 months ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 8 days ago FDA Grants Fast Track Designation to Potential Treatment for Clear Cell Renal Cell Carcinoma - 2 months ago FDA Grants Breakthrough Therapy Designation to NVL-520 for ROS1-Positive NSCLC - 7 months ago Pharmacists Play Key Role Navigating Changing Lines of Therapy for Renal Cell Carcinoma - 7 months ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - 9 months ago FDA Approves Enzalutamide for Nonmetastatic Castration-Sensitive Prostate Cancer - 10 months ago FDA Approves Repotrectinib for Treatment of ROS1-Positive NSCLC - 10 months ago FDA Grants Priority Review to New Drug Application for Belzutifan for Advanced Renal Cell Carcinoma - 12 months ago
4	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 4 months ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	The latest updates on cancer research from the weekend - 5 months ago
6	Emily Cooke Live Science Health reporter. London, United Kingdom healthscience	Designer immune-cell therapy could shrink deadly brain tumors, early trials show - 6 months ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Novel Chemotherapy Method Could Decrease Lung Cancer Tumor Size - 7 months ago Researchers Highlight Need for Additional Research in Advanced Non–Small Cell Lung Cancer - 7 months ago
8	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	Lutetium Lu 177 Dotatate Reduced Risk of Death By 72% Compared to Comparator in Patients With Advanced GEP-NETs - 8 months ago
9	Randy Dotinga MedPage Today Indie scribbler, advocate. Board member, @ahcj. San Diego WritingAdvocacy	EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk - 8 months ago
10	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	ProfoundBio's Rinatabart Sesutecan Granted FDA Fast Track Designation for Ovarian Cancer - 9 months ago Zelix Pharmaceuticals Files BLA for PET Imaging Agent for Renal Cell Carcinoma - 9 months ago FDA Grants Fast Track, Breakthrough Designations to CG Oncology Inc’s Cretostimogene Grenadenorepvec - 9 months ago FDA Approves Merck's Welireg for Advanced Renal Cell Carcinoma - 9 months ago

Journalists covering renal cell carcinoma